NCT06935409: Study of HS-20093 Versus Gemcitabine in Combination With Docetaxel in Treatment of Osteosarcoma After Previous Second-line Treatment Failure
- State
- Completed
- Phase
- Phase 3
- People
- 122 taking part
- Started
- 25 Apr 2025
- Primary completion
- 17 Jun 2026
- Arms
- HS-20093
- Results
- None posted
- 20 Apr 2025: Trial registered
- 25 Apr 2025: Trial started
- 7 Sep 2026: Trial completed